Mary D. Adrian

751 total citations
18 papers, 613 citations indexed

About

Mary D. Adrian is a scholar working on Genetics, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Mary D. Adrian has authored 18 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 5 papers in Organic Chemistry and 5 papers in Molecular Biology. Recurrent topics in Mary D. Adrian's work include Estrogen and related hormone effects (12 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Mary D. Adrian is often cited by papers focused on Estrogen and related hormone effects (12 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Mary D. Adrian collaborates with scholars based in United States and Sweden. Mary D. Adrian's co-authors include Henry U. Bryant, Masahiko Sato, Ellen R. Rowley, Charles H. Turner, Timothy A. Grese, Diane L. Phillips, Andrew L. Glasebrook, Lorri L. Short, Harlan W. Cole and Tongyu Wang and has published in prestigious journals such as Analytical Biochemistry, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Mary D. Adrian

17 papers receiving 593 citations

Peers

Mary D. Adrian
Philipp Y. Maximov United States
Pamela K. Shetler United States
Ellen R. Rowley United States
Hubert Maehr United States
Joanna M. Day United Kingdom
Joan S. Lewis United States
Ronald Grigg United Kingdom
Kato L. Perlman United States
Jean Shearin United States
Y. Nishino Germany
Philipp Y. Maximov United States
Mary D. Adrian
Citations per year, relative to Mary D. Adrian Mary D. Adrian (= 1×) peers Philipp Y. Maximov

Countries citing papers authored by Mary D. Adrian

Since Specialization
Citations

This map shows the geographic impact of Mary D. Adrian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary D. Adrian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary D. Adrian more than expected).

Fields of papers citing papers by Mary D. Adrian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary D. Adrian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary D. Adrian. The network helps show where Mary D. Adrian may publish in the future.

Co-authorship network of co-authors of Mary D. Adrian

This figure shows the co-authorship network connecting the top 25 collaborators of Mary D. Adrian. A scholar is included among the top collaborators of Mary D. Adrian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary D. Adrian. Mary D. Adrian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Adrian, Mary D., et al.. (2024). Optimizing light conditions for enhanced strawberry growth in tropical lowlands. Acta Agrobotanica. 77. 1–17.
2.
Krishnan, Venkatesh, Yanfei Li, Catherine Z. Chen, et al.. (2017). Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism. British Journal of Pharmacology. 175(2). 262–271. 13 indexed citations
3.
Li, Yanfei, Matthew Hamang, Nicoletta Bivi, et al.. (2016). Time course of disassociation of bone formation signals with bone mass and bone strength in sclerostin antibody treated ovariectomized rats. Bone. 97. 20–28. 14 indexed citations
4.
Carson, Matthew W., J.G. Luz, Chen S. Suen, et al.. (2014). Glucocorticoid Receptor Modulators Informed by Crystallography Lead to a New Rationale for Receptor Selectivity, Function, and Implications for Structure-Based Design. Journal of Medicinal Chemistry. 57(3). 849–860. 25 indexed citations
5.
Agholme, Fredrik, Brandon R. Macias, Mary D. Adrian, et al.. (2013). Efficacy of a sclerostin antibody compared to a low dose of PTH on metaphyseal bone healing. Journal of Orthopaedic Research®. 32(3). 471–476. 21 indexed citations
6.
Ma, Yanfei, Qinghe Zeng, Allen Schmidt, et al.. (2009). Low dose teriparatide [RHPTH (1–34)] is more efficacious than strontium ranelate in osteopenic ovariactomized rats. Bone. 44. S450–S450. 1 indexed citations
7.
Wallace, Owen B., Jeffrey A. Dodge, Scott A. May, et al.. (2006). A Selective Estrogen Receptor Modulator for the Treatment of Hot Flushes. Journal of Medicinal Chemistry. 49(3). 843–846. 29 indexed citations
8.
Geiser, Andrew G., Conrad W. Hummel, Michael W. Draper, et al.. (2005). A New Selective Estrogen Receptor Modulator with Potent Uterine Antagonist Activity, Agonist Activity in Bone, and Minimal Ovarian Stimulation. Endocrinology. 146(10). 4524–4535. 42 indexed citations
9.
Wallace, Owen B., Henry U. Bryant, Pamela K. Shetler, Mary D. Adrian, & Andrew G. Geiser. (2005). Benzothiophene and Naphthalene Derived Constrained SERMs.. ChemInform. 36(4). 1 indexed citations
10.
Wallace, Owen B., Henry U. Bryant, Pamela K. Shetler, Mary D. Adrian, & Andrew G. Geiser. (2004). Benzothiophene and naphthalene derived constrained SERMs. Bioorganic & Medicinal Chemistry Letters. 14(20). 5103–5106. 8 indexed citations
11.
Helvering, Leah M., Mary D. Adrian, Andrew G. Geiser, et al.. (2004). Differential Effects of Estrogen and Raloxifene on Messenger RNA and Matrix Metalloproteinase 2 Activity in the Rat Uterus. Biology of Reproduction. 72(4). 830–841. 29 indexed citations
12.
Lugar, Charles W., David E. Magee, Mary D. Adrian, et al.. (2003). B-Ring unsaturated estrogens: biological evaluation of 17α-Dihydroequilein and novel B-Nor-6-thiaequilenins as tissue selective estrogens. Bioorganic & Medicinal Chemistry Letters. 13(24). 4281–4284. 10 indexed citations
13.
Grese, Timothy A., Mary D. Adrian, Diane L. Phillips, et al.. (2001). Photochemical Synthesis of N-Arylbenzophenanthridine Selective Estrogen Receptor Modulators (SERMs). Journal of Medicinal Chemistry. 44(17). 2857–2860. 18 indexed citations
14.
Sato, Masahiko, Charles H. Turner, Tongyu Wang, et al.. (1998). LY353381.HCl: A Novel Raloxifene Analog with Improved SERM Potency and Efficacy In Vivo. Journal of Pharmacology and Experimental Therapeutics. 287(1). 1–7. 101 indexed citations
15.
Frolik, Charles A., et al.. (1998). Development of a Scintillation Proximity Assay for High-Throughput Measurement of Intact Parathyroid Hormone. Analytical Biochemistry. 265(2). 216–224. 3 indexed citations
16.
Turner, Russell T., Glenda L. Evans, James P. Sluka, et al.. (1998). Differential Responses of Estrogen Target Tissues in Rats Including Bone to Clomiphene, Enclomiphene, and Zuclomiphene*. Endocrinology. 139(9). 3712–3720. 28 indexed citations
17.
Grese, Timothy A., Lewis D. Pennington, James P. Sluka, et al.. (1998). Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues:  Highly Potent Selective Estrogen Receptor Modulators. Journal of Medicinal Chemistry. 41(8). 1272–1283. 118 indexed citations
18.
Grese, Timothy A., Alexander G. Godfrey, Charles D. Jones, et al.. (1997). Structure−Activity Relationships of Selective Estrogen Receptor Modulators:  Modifications to the 2-Arylbenzothiophene Core of Raloxifene. Journal of Medicinal Chemistry. 40(2). 146–167. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026